Nabriva Therapeutics Plc (NBRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBRV | QNCX | IMRX | ||
| Company | Nabriva Therapeutics Plc | Quince Therapeutics Inc | Immuneering Corp Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.4500 | 1.0500 | 1.4900 | ||
| High | 1.9000 | 1.1000 | 1.5300 | ||
| Low | 1.3500 | 1.0500 | 1.3800 | ||
| Last | 1.4200 | 1.0550 | 1.4800 | ||
| Change | unch | -0.0050 | +0.0100 | ||
| % Change | unch | -0.47% | +0.68% | ||
| Volume | 717,200 | 25,245 | 594,198 | ||
| 20-Day Average Volume | 46,640 | 96,602 | 518,100 | ||
| Previous Close | 1.4200 | 1.0600 | 1.4700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.5446 | 1.0347 | 1.9178 | ||
| 20-Day Raw Stochastic | 12.73% | 71.77% | 7.35% | ||
| 20-Day Relative Strength | 42.54% | 46.56% | 27.68% | ||
| Weighted Alpha | -50.30 | -27.85 | -65.77 | ||
| Today's Opinion | 100% Sell | 56% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 56% Sell | 100% Sell | ||
| Last Month's Opinion | 88% Sell | 40% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.35% since 07/24/23 | -0.47% since 04/22/24 | -13.95% since 04/22/24 | ||
| Low | 1.3500 on 07/31/23 | 0.9800 on 04/26/24 | 1.3800 on 04/29/24 | ||
| High | 1.9000 on 07/31/23 | 1.1199 on 04/24/24 | 1.7300 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -5.96% since 06/30/23 | -0.47% since 03/28/24 | -48.79% since 03/28/24 | ||
| Low | 1.3500 on 07/31/23 | 0.8900 on 04/12/24 | 1.3800 on 04/29/24 | ||
| High | 1.9000 on 07/31/23 | 1.1400 on 04/01/24 | 3.1500 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | -11.26% since 04/28/23 | -15.60% since 01/29/24 | -77.05% since 01/29/24 | ||
| Low | 1.3500 on 07/31/23 | 0.8900 on 04/12/24 | 1.3800 on 04/29/24 | ||
| High | 2.2400 on 05/19/23 | 1.4200 on 02/26/24 | 7.6800 on 03/04/24 | ||
| 6-Month | |||||
| %Chg | -8.39% since 01/30/23 | +8.75% since 10/27/23 | -70.40% since 10/27/23 | ||
| Low | 1.2600 on 03/27/23 | 0.8400 on 11/20/23 | 1.3800 on 04/29/24 | ||
| High | 2.2400 on 05/19/23 | 1.4301 on 01/19/24 | 8.8900 on 12/04/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 45,461 | 45,808 | 43,590 | ||
| Shares Outstanding, K | 32,015 | 43,215 | 29,653 | ||
| Annual Sales | 36,940,000 | 0 | 0 | ||
| Annual Net Income | -57,190,000 | -31,390,000 | -53,470,000 | ||
| Last Quarter Sales | 7,590,000 | 0 | 0 | ||
| Last Quarter Net Income | -8,700,000 | -8,890,000 | -15,080,000 | ||
| 60-Month Beta | 1.53 | 1.25 | -0.89 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.72 on 05/22/23 | -0.21 on 04/01/24 | -0.52 on 03/01/24 | ||
| Latest Earnings Date | 08/02/23 | 05/20/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||